BioCentury
ARTICLE | Financial News

Cardeas raises $34M in series B

May 24, 2013 12:34 AM UTC

Infectious disease company Cardeas Pharma Corp. (Seattle, Wash.) raised $34 million in a series B round led by new investor H.I.G. BioVentures. Existing investors Novo A/S; Avalon Ventures; Devon Park Bioventures; and WRF Capital also participated, along with new investor Delphi Ventures. H.I.G. BioVentures' Aaron Davidson will join Cardeas' board. ...